![](/pharma/pharma_aug20/contents/895661/1_content.480_0_1.jpg)
Charting the history of Genomics England from rare diseases to Covid-19 research
![](/pharma/pharma_aug20/contents/895663/2_content.480_0_1.jpg)
What can pharma companies learn from previous financial crises?
![](/pharma/pharma_aug20/contents/895664/3_content.512_0_1.jpg)
Pharma is under pressure to ensure equitable access to a Covid-19 vaccine
![](/pharma/pharma_aug20/contents/895665/4_content.480_0_1.jpg)
Does the supply chain have the capacity to produce enough product to meet demand?
![](/pharma/pharma_aug20/contents/895670/5_content.480_0_1.jpg)
Innovative Trials explains what it takes to match the right participant to the right trial
![](/pharma/pharma_aug20/contents/895662/6_content.480_0_1.jpg)
Recce Pharma may have discovered the next frontier in the fight against AMR
![](/pharma/pharma_aug20/contents/895668/7_content.480_0_1.jpg)
Examining the current state of the autism pipeline and the future of ASD treatment
![](/pharma/pharma_aug20/contents/895666/9_content.480_0_1.jpg)
Could a new crystallography technique help accelerate drug development?
![](/pharma/pharma_aug20/contents/895667/9_content_1.480_0_1.jpg)
Legislators in the US are pushing to allow funding of psychedelics research
![](/pharma/pharma_aug20/contents/895669/10_content.400_0_1.jpg)
Graph technology may be the solution for fixing broken supply chains